Genetic and Genomic Results in Clinical Practice: Managing Uncertainty and Maximizing Patient Benefit
CME (AMA PRA Category 1 Credits™) 2.0; Attendance CEU 2.0

Sunday, October 8
3:30 PM - 5:30 PM

Clinical genetic and genomic testing is becoming increasingly informative for determining the diagnosis, prognosis, disease risk, and optimal therapeutic strategies for patients. The genetic and genomic testing repertoire is diverse, varying by the underlying testing methodology and the type of variants detected, the scale of the test (single gene/variant to genome-wide), as well as the intent of the test. The results of this testing are complex, often accompanied by uncertainty, and may impact patients throughout their lives. Thus, the appropriate interpretation, communication, and management of results is paramount to optimizing patient care.

This session brings together experts in the fields of Clinical Genomics, Oncology, Pharmacogenomics, and Genetic Counseling to guide the audience through complexities of genetic and genomic testing.

Learning Objectives:

Matthew Bernard

Associate Professor of Family Medicine, College of Medicine
Mayo Clinic

Matthew Bernard, MD, is a Family Physician at the Mayo Clinic in Rochester, MN, where he has been in practice for 22 years. He is an Associate Professor and Chair of the Family Medicine Department. Dr. Bernard has an interest in the education of clinicians on how to practically integrate genomic information into clinical practice. He has developed continuing medical education conferences on genomic medicine in clinical practice.
Dr. Bernard received his M.D. from the University of Minnesota School of Medicine and completed his Family Medicine residency training at the Mayo School of Graduate Education.


Send Email for Matthew Bernard

Brendan Lanpher

Assistant Professor of Medical Genetics
Mayo Clinic

Brendan Lanpher, MD, is a physician in the Department of Clinical Genomics at the Mayo Clinic in Rochester, MN. Brendan is an Assistant Professor in the College of Medicine. Clinical interests include inborn errors of metabolism and dysmorphic syndromes. Brendan has been a clinical geneticist for 10 years and has been on the faculty at the Mayo Clinic for one year. He has been active in overseeing newborn screening activities in multiple states and as an advisor to newborn screening programs internationally.


Send Email for Brendan Lanpher

Alan Bryce

Assistant Professor of Medicine, College of Medicine
Mayo Clinic

Alan H. Bryce, M.D., is a physician in the Division of Hematology and Oncology, Department of Internal Medicine at Mayo Clinic Arizona and serves as vice chair and practice chair of the division. He currently serves as medical director of the Genomic Oncology Clinic at Mayo Clinic in Arizona. He holds the academic rank of assistant professor of medicine, Mayo Clinic College of Medicine. He joined the staff of Mayo Clinic in 2011.

Dr. Bryce earned his B.S. degree in biochemistry at University of California, Los Angeles, and his M.D. degree at Finch University of Health Sciences, Chicago Medical School. He completed a residency in internal medicine and a fellowship and chief fellowship in hematology/oncology at Mayo Graduate School of Medicine.

Dr. Bryce's research centers on understanding the genetic mutations of individual cancer cells in order to allow for a precise, targeted treatment strategy. The ultimate goal is for every patient to have their tumor biopsied and sequenced, resulting in a personalized treatment plan. In his leadership role with the Genomic Oncology Clinic, he utilizes whole genome sequencing of tumors to identify key driver mutations. This approach allows for precise targeting of a patient's tumor, leading to a greater chance of remission. Dr. Bryce participates in community outreach to underserved populations and has in interest in health disparities research. He has authored numerous journal articles, abstracts and other written publications.
Dr. Bryce has received numerous awards and honors, including the Excellence in Teaching Recognition Award, conferred by Mayo Medical School, Mayo Clinic College of Medicine; the Young Investigator Award, conferred by the American Journal of Hematology; the Oncology Scholar in Training Award, conferred by the American Association of Cancer Research, Bristol-Myers Squibb; and the Outstanding Trainee Award, conferred by the Hematology/Oncology Fellowship Program, Mayo Clinic.


Send Email for Alan Bryce

Teresa Kruisselbrink

Supervisory Genetic Counselor
Mayo Clinic Center for Individualized Medicine

Teresa Kruisselbrink is Genetic Counselor Supervisor in the Mayo Clinic Center for Individualized Medicine. She began her career in 1997 at Mayo Clinic by establishing the role of the laboratory based genetic counselor in Molecular Genetics, Biochemical Genetics, Cytogenetics and Maternal Serum Screening. She has provided genetic counseling in Medical Genetics, neurology, obstetrics, cardiology and outreach clinics. Ms. Kruisselbrink contributes to numerous educational programs including Mayo Medical School, Graduate School, and fellowship and residency programs in the laboratory and clinical environments. She is also actively involved in mentoring high school and college students wishing to pursue a career in genetic counseling. Teresa received her B.S. in Molecular, Cellular, Developmental Biology and Genetics and M.S. in Genetic Counseling from the University of Minnesota. She is an Instructor of Laboratory Medicine and Pathology.


Send Email for Teresa Kruisselbrink

Eric Matey

Mayo Clinic

Eric Teye Matey PharmD, RPh, BCACP, has been a pharmacist at Mayo Clinic since graduating from Howard University School of Pharmacy in 2004. From 2006 through 2009, he worked with Mayo Specialty Pharmacist in charge of Growth Hormone Deficiency, Primary Immune Deficiency and Hepatitis C. In this capacity, he collaborated with specialists in these fields to ensure appropriate medication dosing and patient education for optimal medication experience. In 2009, he began working within the clinic as a Medication Therapy Management (MTM) pharmacist with interest in pharmacogenomics and Macrobacterium Avium Complex (MAC). He became a Board Certified Ambulatory Care Pharmacist (BCACP) in 2012, the second year that the Board of Pharmacy Specialties offered the ambulatory care specialty exam. Dr. Eric Teye Matey volunteer at the salvation clinic in the past with Dr. Robert Hoel with a focus on diabetes education and medication management for underserved patient population in Rochester MN. In his spare time, he enjoys biking and as captain of Team Humphrey’s (Tour de Cure-ADA) continues to raise funds for diabetes research and awareness. He is a board member of Africa Partners Medical, a nonprofit organization, which primary goal is to stop needless death in Africa. Professional memberships include MPhA, APhA, ACCP and ASHP.


Send Email for Eric Matey


Genetic and Genomic Results in Clinical Practice: Managing Uncertainty and Maximizing Patient Benefit
CME (AMA PRA Category 1 Credits™) 2.0; Attendance CEU 2.0

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Genetic and Genomic Results in Clinical Practice: Managing Uncertainty and Maximizing Patient Benefit
CME (AMA PRA Category 1 Credits™) 2.0; Attendance CEU 2.0